Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Preferred Stock Liabilities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Preferred Stock Liabilities for 5 consecutive years, with $10.5 million as the latest value for Q1 2020.

  • On a quarterly basis, Preferred Stock Liabilities changed 0.0% to $10.5 million in Q1 2020 year-over-year; TTM through Mar 2020 was $10.5 million, a 0.0% change, with the full-year FY2019 number at $10.5 million, up 85.81% from a year prior.
  • Preferred Stock Liabilities was $10.5 million for Q1 2020 at Forte Biosciences, roughly flat from $10.5 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $131.4 million in Q4 2016 to a low of $67000.0 in Q1 2017.
  • A 5-year average of $23.7 million and a median of $10.5 million in 2019 define the central range for Preferred Stock Liabilities.
  • Peak YoY movement for Preferred Stock Liabilities: surged 85.81% in 2019, then changed 0.0% in 2020.
  • Forte Biosciences' Preferred Stock Liabilities stood at $131.4 million in 2016, then tumbled by 99.95% to $67000.0 in 2017, then surged by 8346.27% to $5.7 million in 2018, then soared by 85.81% to $10.5 million in 2019, then changed by 0.0% to $10.5 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Preferred Stock Liabilities are $10.5 million (Q1 2020), $10.5 million (Q4 2019), and $10.5 million (Q3 2019).